Pancreatic Cancer Research

ResearcherMayo ClinicActive in the last 2 years

Heike R. Döppler

Matched on OpenAlex author ID A5062388236. Sources: OpenAlex.

Their work

Papers
9 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: 1 paper · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: 2 papers · 2025: 2 papers

Papers 9

  1. A vaccination strategy to prevent coxsackie virus B3-induced development of pancreatic cancer. First author DOI 10.1172/jci.insight.192629↗
  2. Downregulation of Sod2 increases atypical flat lesions and dysplasia to advance pancreatic ductal adenocarcinoma. First author DOI 10.1186/s12943-025-02518-0↗
  3. Coxsackievirus and adenovirus receptor expression facilitates enteroviral infections to drive the development of pancreatic cancer. Co-author DOI 10.1038/s41467-024-55043-x↗
  4. Macrophage-induced reactive oxygen species in the initiation of pancreatic cancer: a mini-review. Co-author DOI 10.3389/fimmu.2024.1278807↗
  5. Ym1+ macrophages orchestrate fibrosis, lesion growth, and progression during development of murine pancreatic cancer. First author DOI 10.1016/j.isci.2022.104327↗
  6. Sangivamycin and its derivatives inhibit Haspin-Histone H3-survivin signaling and induce pancreatic cancer cell death. Co-author DOI 10.1038/s41598-019-53223-0↗
  7. Mitochondrial and Oxidative Stress-Mediated Activation of Protein Kinase D1 and Its Importance in Pancreatic Cancer. Co-author DOI 10.3389/fonc.2017.00041↗
  8. The PRKD1 promoter is a target of the KRas-NF-κB pathway in pancreatic cancer. Co-author DOI 10.1038/srep33758↗
  9. Downregulation of TRAF2 mediates NIK-induced pancreatic cancer cell proliferation and tumorigenicity. Co-author DOI 10.1371/journal.pone.0053676↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Peter Störz · 9 shared papers, 2013–2025 · strength 1.77
  2. Ligia I. Bastea · 6 shared papers, 2016–2025 · strength 1.10
  3. Alicia K. Fleming Martinez · 4 shared papers, 2022–2025 · strength 0.91
  4. Veethika Pandey · 2 shared papers, 2024–2025 · strength 0.44
  5. Geou‐Yarh Liou · 2 shared papers, 2013–2022 · strength 0.25
  6. E. Aubrey Thompson · 1 shared paper, 2024 · strength 0.18
  7. Lizhi Zhang · 1 shared paper, 2024 · strength 0.18
  8. Michael Anthony Hollingsworth · 1 shared paper, 2024 · strength 0.18
  9. Paul M. Grandgenett · 1 shared paper, 2024 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.